Pulse ·
PMD and mental health: the bidirectional link GPs need to act on
A Karolinska Institutet study published in JAMA Network Open (June 2026) found strong bidirectional associations between premenstrual disorders (PMD) and psychiatric conditions. Women with PMD were more than twice as likely to develop a psychiatric disorder; women with existing psychiatric disorders were more than twice as likely to develop PMD.
The strongest associations were with depression and anxiety. Additional links were found for ADHD, bipolar disorder, and personality disorder. No significant association emerged for schizophrenia. These findings support integrated reproductive and mental health screening in general practice consultations.
If you are supporting women managing premenstrual symptoms alongside mood or anxiety difficulties — or running in the other direction, managing a psychiatric condition in someone with cyclical reproductive symptoms — new research formalises what many GPs have observed in practice: the relationship is genuinely bidirectional, and the risk is substantial in both directions.
A large study from the Karolinska Institutet, published in JAMA Network Open on 16 June 2026, found that women with premenstrual disorders were more than twice as likely to develop a psychiatric disorder as women without PMD. The reverse was equally pronounced: women with established psychiatric conditions were more than twice as likely to develop premenstrual disorder symptoms.
That symmetry is the headline. But the clinical granularity underneath it matters for how general practice responds.
What the study found
Thirty-seven percent of women with premenstrual disorders developed a psychiatric disorder during the study period. Among women with psychiatric conditions, 14% developed PMD. The rates are different — a woman with PMD has a higher absolute probability of acquiring a psychiatric disorder than the reverse — but both associations were statistically robust and clinically meaningful.
The strongest bidirectional links were with depression and anxiety. The study also found associations — in both directions — with ADHD, bipolar disorder, and personality disorder. Schizophrenia was the notable exception: no significant association was found in either direction, which is a useful negative finding because it suggests the shared pathway is not simply any psychiatric vulnerability, but something more specific to mood-spectrum and neurodevelopmental conditions.
The Karolinska team’s work builds on a growing evidence base linking cyclical reproductive hormonal exposure to mood vulnerability. The bidirectionality is consistent with a shared neurobiological substrate — sensitivity to hormonal fluctuations, possibly mediated through serotonergic and GABAergic systems — but the study characterises association rather than mechanism.
Both-and
There is a version of this finding that could be read reductively: “PMD is really a psychiatric condition.” That framing would be wrong, and unhelpful to patients who have spent years being told their cyclical symptoms are “just mood” or “just hormones” by clinicians on both sides of the reproductive–psychiatric divide.
What the data actually shows is a shared vulnerability that manifests in both directions. A woman with severe premenstrual dysphoric disorder is not simply depressed at a specific phase of her cycle; she has a biological system differentially sensitive to hormonal change in a way that also, separately, increases her psychiatric disorder risk. The reverse — someone managing depression or ADHD who develops worsening premenstrual symptoms — is not having her mood disorder relabelled; she is experiencing a separate but mechanistically related process.
The bidirectionality is the finding, not a signal that one condition subsumes the other. General practice consultations can hold both.
The clinical risk with a finding like this is the temptation toward diagnostic collapse: once we know about the link, we might over-attribute every mood symptom in a woman with PMDD to her PMDD, or over-interpret every premenstrual complaint in someone with depression as a mood episode. The evidence supports screening in both directions — not collapsing the diagnostic categories.
My two cents
Two practical implications for the consultation room.
First: if a patient presents with depression, anxiety, ADHD, bipolar disorder, or personality disorder, it is worth asking specifically about cyclical symptom patterns. Not as an aside, but as a structured question. The bidirectional association means the PMD dimension may be contributing, cyclically amplifying, or requiring separate treatment alongside the primary psychiatric diagnosis. Daily symptom tracking over two cycles remains the most useful diagnostic tool for identifying that pattern.
Second: if a patient presents with premenstrual disorder symptoms — especially PMDD — proactive enquiry about mood and anxiety history is warranted. Thirty-seven percent developing a psychiatric disorder is not a small signal; it is a clinically meaningful elevated risk that should inform how closely these patients are followed and whether their treatment plan addresses the psychiatric dimension.
The current system does not do this well. Premenstrual disorders tend to sit in gynaecology or general practice without systematic psychiatric screening. Psychiatric services tend to see cyclical reproductive symptoms as outside their scope. The patient navigates both. This evidence is a reasonable basis for general practice taking a more integrated approach — not by becoming specialists in both, but by maintaining awareness of both dimensions in every consultation with affected patients.
Verdict: yes — well-evidenced bidirectional associations that change the screening conversation in general practice for women with either PMD or mood and anxiety disorders.